Miller, J. S., Felices, M., Phung, S. K., Matson, A. W., Wang, S., Friess, R. R., . . . Truckenbrod, E. N. Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMiller, Jeffrey S., et al. Enhanced IL-15-mediated NK Cell Activation and Proliferation by an ADAM17 Function-blocking Antibody Involves CD16A, CD137, and Accessory Cells. BMJ Publishing Group.
MLA (9th ed.) CitationMiller, Jeffrey S., et al. Enhanced IL-15-mediated NK Cell Activation and Proliferation by an ADAM17 Function-blocking Antibody Involves CD16A, CD137, and Accessory Cells. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.